Ontario company seeks licence to make generic Johnson and Johnson COVID vaccine for developing countries

  • 📰 nationalpost
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 80%

Business News News

Business Business Latest News,Business Business Headlines

A compulsory licence can be granted when a company demonstrates a clear need for generic versions of patented medicine

AdvertisementBiolyse has sought and received a compulsory licence before, for the influenza drug Tamiflu during the H1N1 scare, but the process took seven months and the flu had largely run its course when it received approval. Compulsory licences were also issued to generic drug giant Apotex to send AIDS medications to Rwanda.

“If you can’t use a compulsory licence now, you can’t use Canada’s access to medicines regime now, then what’s the use?” Even with that licence, Johnson and Johnson would not be under any obligation to help Biolyse manufacture the vaccine, it just would have no recourse to stop it under patent law.Article content

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Who comes first. Canadians or developing countries. This covid19 has taught us one thing here in Canada. We have no Leadership in Ottawa, and JT always goes to China asking for help, instead of doing what GB did.

Developing countries At this point Canada is a Developing country with Trudeau's vaccine failure👎

Better idea: make it for the Canadian market as well.

Cool!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 10. in BUSİNESS

Business Business Latest News, Business Business Headlines